Healthcare | December 08, 2025
Bengaluru healthtech firm Biomoneta secures USFDA nod for air purifier
Captured microbes are then neutralized on engineered microbicidal surfaces
Captured microbes are then neutralized on engineered microbicidal surfaces
76 of 180 long COVID-associated genes also linked to ME
Biocon will acquire the residual stake held by Mylan (Viatris) for a total consideration of US$ 815 million
Peapod Bio’s proprietary technologies can efficiently identify inhibitors and binding molecules for virtually any target
Terray and BMS aim to accelerate small molecule drug discovery by harnessing EMMI’s integrated experimental and AI capabilities
Implementing PFAS testing in the early development stages allows medical device manufacturers to prepare for potential regulatory updates
Grant of Permission to manufacture and market FDC of Naproxen Delayed Release and Esomeprazole capsule (375mg/500mg + 20mg/20mg)
The partnership targets breakthroughs in Alzheimer’s disease, diabetes, cancer, and cell and gene therapy
This inspection was conducted following the warning letter issued by the USFDA
Health Canada’s approval was based on a comprehensive evaluation of analytical, nonclinical, and clinical data
Subscribe To Our Newsletter & Stay Updated
